Guangdong, Tianjin, China The leading representative office of defined Corporate Investor is situated in the Tianjin. The venture was found in Asia in China.
Among the most popular portfolio startups of the fund, we may highlight iCarbonX, Genetron Health. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Artificial Intelligence, Biotechnology. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The top activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of more than 100 millions dollars are the general things for fund. The typical startup value when the investment from Zhongyuan Union Cell & Gene Eng is more than 1 billion dollars.
The usual cause for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Share Capital, New Horizon Capital. In the next rounds fund is usually obtained by Zhongjin Kangrui Medical Industrial Fund, Vivo Capital, V Star Capital.
Related Funds
| Fund Name | Location |
| Arbor Capital | - |
| BACH Wirtschafts-Consulting | - |
| Harmony Labs | - |
| Hyosung ITX | Seoul-t'ukpyolsi, South Korea, Yongdungpo |
| Microfinace Initiative for Asia | - |
| MTP Connect | - |
| Power Sun Ventures | China, Guangdong, Shenzhen |
| Venrex Investment Management | England, London, United Kingdom |
| Wecash | Beijing, Beijing, China |
| WS Capital Management | Dallas, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Genetron Health | 20 Sep 2016 | Dongcheng District, Beijing, China | |||
iCarbonX | $155M | 13 Apr 2016 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Genetron Health | 20 Sep 2016 | Dongcheng District, Beijing, China | |||
iCarbonX | $155M | 13 Apr 2016 | Futian District, Guangdong Province, China |
